Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma

Journal of Chromatography A

Volumn 1119, Issue 1-2, 2006, Pages 309-314

  Ferreiros N ^a   Iriarte, G ^a   Alonso, R M ^a   Jimenez R M ^a   Ortiz E ^b  

^a Grupo de Nuevos Materiales y Espectroscopia Supramolecular   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Eprosartan; Human plasma; Liquid chromatography; Solid phase extraction; Validation

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PATIENT TREATMENT; PHARMACODYNAMICS; PLASMAS;

EPROSARTAN; HUMAN PLASMA; SOLID PHASE EXTRACTION; VALIDATION;

DRUG PRODUCTS;

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPROSARTAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACCURACY; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG STABILITY; DRUG STORAGE; EXPERIMENTAL DESIGN; HUMAN; MEASUREMENT; MEASUREMENT ERROR; PHOTOMETRY; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STANDARD; STORAGE TEMPERATURE; VALIDATION STUDY;

ACRYLATES; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; IMIDAZOLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THIOPHENES;

EID: 33744828671     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2006.02.055     Document Type: Article

References (19)

1. Sorof J., and Daniels S. Hypertension 40 (2002) 441
2. Chamberlain J. Special Problems with Biological Fluids. The Analysis of Drugs in Biological Fluids (1995), CRC Press, Boca Raton, FL p. 35
3. Braggio S., Barnabi R.J., Grossi P., and Cugola M. J. Pharm. Biomed. Anal. 14 (1996) 375
4. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville, MD, May 2001.
5. Text on Validation of Analytical Procedures Q2A, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, London 1994.
6. Validation of Analytical Procedures: Methodology Q2B, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, London 1996.
7. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
8. James C.A., Breda M., and Frigerio E. J. Pharm. Biomed. Anal. 35 (2004) 887
9. Ilson B., Boike S., Freed M., Everitt D., Brown L., Zariffa N., and Jorkasky D. Clin. Pharmacol. Ther. 55 (1994) 206
10. Ilson B., Tenero D., Knox S., Boike S., Audet A., Freed M., Everitt D., Brown L., Boyle D., and Jorkasky D. Clin. Pharmacol. Ther. 55 (1994) 168
11. Hillaert S., and Van den Bossche W. J. Chromatogr. A 979 (2002) 323
12. Hillaert S., and Van den Bossche W. J. Pharm. Biomed. Anal. 31 (2003) 329
13. Hillaert S., De Beer T.R.M., De Beer J.O., and Van den Bossche W. J. Chromatogr. A 984 (2003) 135
14. Gonzalez L., Alonso R.M., and Jimenez R.M. Chromatographia 52 (2000) 735
15. Cagigal E., Gonzalez L., Alonso R.M., and Jimenez R.M. Talanta 54 (2001) 1121
16. Gonzalez L., Lopez J.A., Alonso R.M., and Jimenez R.M. J. Chromatogr. A 949 (2002) 49
17. Torrealday N., Gonzalez L., Alonso R.M., Jimenez R.M., and Ortiz Lastra E. J. Pharm. Biomed. Anal. 32 (2003) 847
18. Lundberg D.E., Person R.C., Knox S., and Cyronak M.J. J. Chromatogr. B 707 (1998) 328
19. N. Ferreirós, G. Iriarte, R.M. Alonso, R.M. Jiménez, Talanta, in press.